90
Views
10
CrossRef citations to date
0
Altmetric
Review

Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options

, , , &
Pages 17-23 | Published online: 03 Feb 2010

References

  • CramerJAMattsonRHPreveyMLScheyerRDOuelletteVLHow often is medication taken as prescribed? A novel assessment techniqueJAMA1989 926122327332772716163
  • Breekveldt-PostmaNSKoerselmanJErkensJAvan der MolenTLammersJWHeringsRMTreatment with inhaled corticosteroids in asthma is too often discontinuedPharmacoepidemiol Drug Saf200817441142218205251
  • VermeirePARabeKFSorianoJBMaierWCAsthma control and differences in management practices across seven European countriesRespir Med200296314214911905548
  • De MarcoRCazzolettiLCerveriICorsicoABugianiMAccordiniSAre the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthmaInt Arch Allergy Immunol2005138322523416210861
  • BatemanEDBousheyHABousquetJBusseWWClarkTJPauwelsRACan guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL studyAm J Respir Crit Care Med2004170883684415256389
  • JefferyPKGodfreyRWAdelrothENelsonFRogersAJohanssonSAEffects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic studyAm Rev Respir Dis1992145(4 Pt 1):8908991554218
  • JuniperEFKlinePAVanzieleghemMARamsdaleEHO’ByrnePMHargreaveFEEffect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmaticsAm Rev Respir Dis199014248328362221590
  • PauwelsRALofdahlCGPostmaDSTattersfieldAEO’ByrnePBarnesPJEffect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study GroupN Engl J Med199733720140514119358137
  • SuissaSErnstPBenayounSBaltzanMCaiBLow-dose inhaled corticosteroids and the prevention of death from asthmaN Engl J Med2000343533233610922423
  • Global INitiative for Asthma (GINA)Global strategy for asthma management and prevention: NHLBI/WHO workshop reportNational Heart, Lung and Blood InstituteBethesda, MD Updated2006
  • BatemanEDBantjeTAJoao GomesMToumbisMGHuberRMNayaICombination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthmaAm J Respir Med20032327528114720008
  • LallooUGMalolepszyJKozmaDKroftaKAnkerstJJohansenBBudesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthmaChest200312351480148712740264
  • RingdalNElirazAPruzinecRWeberHHMulderPGAkveldMThe salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthmaRespir Med200397323424112645830
  • TalASimonGVermeulenJHPetruVCobosNEverardMLBudesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthmaPediatr Pulmonol200234534235012357478
  • RosenhallLBorgSAnderssonFEricssonKBudesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 monthsInt J Clin Pract200357866266714627174
  • BarnesPJAsthma. New therapeutic approachesBr Med Bull19924812312471352169
  • BrocklebankDWrightJCatesCSystematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthmaBMJ2001323731889690011668133
  • BattagliaSden HertogHTimmersMCLazeromsSPVignolaAMRabeKFSmall airways function and molecular markers in exhaled air in mild asthmaThorax200560863964416061704
  • BourdinAPaganinFPrefautCKieselerDGodardPChanezPNitrogen washout slope in poorly controlled asthmaAllergy2006611858916364161
  • in ’t VeenJCBeekmanAJBelEHSterkPJRecurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodesAm J Respir Crit Care Med200016161902190610852764
  • WagnerEMLiuMCWeinmannGGPermuttSBleeckerERPeripheral lung resistance in normal and asthmatic subjectsAm Rev Respir Dis199014135845882178524
  • PritchardJNThe influence of lung deposition on clinical responseJ Aerosol Med200114Suppl 1S19S2611424889
  • VirchowJCCromptonGKDal NegroRPedersenSMagnanASeidenbergJImportance of inhaler devices in the management of airway diseaseRespir Med20081021101917923402
  • GiraudVRocheNMisuse of corticosteroid metered-dose inhaler is associated with decreased asthma stabilityEur Respir J2002192246245111866004
  • TarsinWYPearsonSBAssiKHChrystynHEmitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmaticsInt J Pharm20063161–213113716584855
  • JanssensWVandenBrandePHardemanEDe LangheEPhilpsTTroostersTInspiratory flow rates at different levels of resistance in elderly COPD patientsEur Respir J2008311788317898020
  • DolovichMBAhrensRCHessDRAndersonPDhandRRauJLDevice selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001
  • Vanden BurgtJABusseWWMartinRJSzeflerSJDonnellDEfficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthmaJ Allergy Clin Immunol200010661209122611112914
  • GoldinJGTashkinDPKleerupECGreaserLEHaywoodUMSayreJWComparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomographyJ Allergy Clin Immunol19991046S258S26710588987
  • AcerbiDBrambillaGKottakisIAdvances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technologyPulm Pharmacol Ther200720329030316890465
  • ThongngarmTSilkoffPEKossackWSNelsonHSHydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthmaJ Asthma200542425726316032934
  • HoughtonCMLangleySJSinghSDHoldenJMonici PretiAPAcerbiDComparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover studyBr J Clin Pharmacol200458435936615373928
  • HuchonGMagnussenHChuchalinADymekLGonodFBBousquetJLung function and asthma control with beclomethasone and formoterol in a single inhalerRespir Med20091031414918977646
  • NicoliniGScichiloneNBizziAPapiAFabbriLMBeclomethasone/formoterol fixed combination for the management of asthma: patient considerationsTher Clin Risk Manag20084585586419209268
  • FabbriLMNicoliniGOlivieriDPapiAInhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectivesExp Opin Pharmacother200893479490
  • DhillonSKeatingGMBeclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhalerDrugs2006661114751483 discussion 84–8516906779
  • PapiAPaggiaroPNicoliniGVignolaAMFabbriLMBeclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthmaAllergy200762101182118817845589
  • PapiAPaggiaroPLNicoliniGVignolaAMFabbriLMBeclomethasone/formoterol versus budesonide/formoterol combination therapy in asthmaEur Respir J200729468268917107988
  • ApterAJAffleckGReisineSTTennenHABarrowsEWellsMPerception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and moodJ Allergy Clin Immunol19979956056129155825
  • HolgateSTPriceDValovirtaEAsthma out of control? A structured review of recent patient surveysBMC Pulm Med20066Suppl 1S217140420
  • KoningsEDubois-ArberFNarringFMichaudPAIdentifying adolescent drug users: results of a national survey on adolescent health in SwitzerlandJ Adolesc Health19951632402477779836
  • MilesJFGardenGMTunnicliffeWSCaytonRMAyresJGPsychological morbidity and coping skills in patients with brittle and non-brittle asthma: a case-control studyClin Exp Allergy19972710115111599383255
  • AaltoAMHarkapaaKAroARRissanenPWays of coping with asthma in everyday life: validation of the Asthma Specific Coping ScaleJ Psychosom Res20025361061106912479987
  • AdamsRJSmithBJRuffinREFactors associated with hospital admissions and repeat emergency department visits for adults with asthmaThorax200055756657310856316
  • AdamsSPillRJonesAMedication, chronic illness and identity: the perspective of people with asthmaSoc Sci Med19974521892019225407
  • BarberNParsonsJCliffordSDarracottRHorneRPatients’ problems with new medication for chronic conditionsQual Saf Health Care200413317217515175485
  • ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
  • FuertesJNMislowackABennettJPaulLGilbertTCFontanGThe physician-patient working alliancePatient Educ Couns2007661293617188453
  • CorsicoAGCazzolettiLde MarcoRJansonCJarvisDZoiaMCFactors affecting adherence to asthma treatment in an international cohort of young and middle-aged adultsRespir Med200710161363136717188854
  • JuniperEFThe impact of patient compliance on effective asthma managementCurr Opin Pulm Med20039Suppl 1S8S1012974536